Blistex bolsters its product portfolio with growth brand from J&J
OAK BROOK, Ill. – Blistex on Tuesday announced the acquisition of the Tucks brand of OTC rectal medications from Johnson & Johnson Consumer.
The transaction closed on July 8 for an undisclosed amount.
“We are delighted to welcome Tucks to the Blistex family of brands,” stated Justin Arch, CEO of Blistex. “Given its efficacious products and strong heritage, Tucks is well positioned to address growing consumer needs within its category, and we expect it to respond positively to our focused model of consumer advertising and promotional support combined with thoughtful innovation.”
The brand is currently outpacing category growth, according to IRI data. For the 52 weeks ended May 15, Tucks generated $19.2 million on a 4.3% sales lift across total U.S. multi-outlet channels. The hemorrhoidal remedies category as a whole is up 1.6% to $117 million.
Blistex is best known as a global leader in lip care, offering a wide range of lip balms with highly effective formulas and unique added benefits under the Blistex brand. Its broader consumer healthcare portfolio includes Odor Eaters, as well as mainstay brands in categories ranging from acne care with Stridex, oral analgesics with Kank-A and itch relief with Ivarest.
Blistex also markets a full line of skin care products under the Glysomed brand that includes the top-selling hand cream in Canada.
Data analytics company Advanced Plan for Health partners with iHealth Labs
IRVING, Texas – Advanced Plan for Health, a provider of data analytics technology to help organizations improve health benefits programs, on Monday announced it is teaming with iHealth Labs, a provider of mobile healthcare monitoring solutions. By integrating with iHealth's mobile health devices and solution, and incorporating the health vitals compiled from iHealth's devices into APH's data analytics engine, employers are able to reduce employee health costs, improve health outcomes and empower individuals to be hands-on managers of their own health.
iHealth's software platform and devices make it easy for consumers to track their health vitals, including blood pressure monitoring, weight, glucose levels, activity levels and blood oxygen levels. The devices automatically sync the data to smartphones or tablets and the information is then uploaded into APH's Poindexter, a data analytics risk engine custom-built for population health management, to provide a complete health picture for each individual.
If an individual shows they are maintaining a chronic condition, this may result in lower health plan co-pays, deductibles or premiums, Advanced Plan stated.
"iHealth's line of mobile health devices and solutions enable our users to lead healthier lives by taking a more active role in managing health conditions like hypertension and diabetes," commented Yuchen Wang, chief solution officer, iHealth Labs. "Through our partnership with Advanced Plan for Health, we're now able to help patients not only better understand their health but also realize savings when it comes to their healthcare expenses."
"We need to encourage individuals to change their mindset from patient to consumer," added Neil Godbey, CEO Avanced Plan for Health. "This behavioral approach is how healthcare is being transformed, and we want to be on the cutting edge of this trend. The end result of this partnership is to provide value – in terms of better health outcomes and savings – to self-funded employers, payors, providers and patients alike."
APH announced last month that it also partnered with digital health company Tesser Health. Together, these partnerships help APH to build consumer health management capabilities into the Poindexter platform.
New supplement manufacturer releases supplement to combat jet lag
TORONTO – Bon Voyage Supplements introduced a solution for jet lag that doesn't cause a crash like many caffeine pills, energy drinks and other supplements do.
Bon Voyage is formulated with a clinically tested ingredient, Neuravena, which works to promote better travel experiences by enhancing alertness, relieving stress and boosting cognitive function.
"I found myself jet lagged on my first business trip from Toronto to Beijing for an entire week, and it completely ruined my experience," stated Youcef Boudouh, CEO Bon Voyage. "On my way back home, I pondered that there must be a natural and safe way to stop jet lag. At the time, I was working in the natural supplement industry as an international business development manager."
Forging an exclusive partnership with Mihai Niculescu at Advanced Nutragenomics, Bon Voyage Supplements validated the formula's ingredients and moved forward with the next steps of introducing their supplement to the consumer market.
In July, Bon Voyage Supplements will launch a crowdfu nding campaign on IndieGoGo to garner awareness and funds to manufacture and ship out their supplement to travelers everywhere.
"Above disrupting the natural supplement industry with a unique product based on hard scientific and clinical facts, we also wanted to create amazing customer experiences online with our social network strategy based on a mindblowing contest, the $10,000 Backpack Trip Contest and weekly Amazon and Starbucks gift cards," stated Mohit Sadarangani, Bon Voyage founder in charge of marketing.
According to Bon Voyage Supplements, they plan to hold similar contests each year.
Bon Voyage Supplements' jet lag formula offers a tablet that is taken twice daily.